In lung cancer, the HSF1 inhibitor induced cancer cell growth arrest and apoptosis and helps to overcome cancer cell resistance to conventional anti-cancer drugs, including paclitaxel and cisplatin [218]. This evidence concerns the gene HSF1 and cancer.